Abstract
The multi-billion veterinary health products market, though smaller in
opportunity as compared with the human health sector, offers significant
return on investment, primarily driven by lower risk and faster product
development cycles. The veterinary health products market has remained
resilient over the economic downturns of the past 2 decades.
This report, World Veterinary Health Products, takes a look at veterinary
health products for both companion (pet) animals, and production animals
(livestock and poultry) and the opportunity for existing players and new
entrants in three segments:
- Pharmaceuticals (including Parasiticides, Anti-infectives, NSAIDS,
Cardiovasculars, Hormones, CNS, Others)
- Veterinary (Pet) OTC Products (Parasiticides, NSAIDS, Vitamins, GI
Disorders, Cold and Cough, Others)
- Performance Enhancers
- Veterinary Vaccines
For each segment, the report includes pet and production animal demographic
information, market forecasts to 2014, major products in the industry, trends
affecting business planning, and competitive activity. Revenues are provided
for U.S., Europe and Rest of World. This report profiles the following key
companies in this industry: This report profiles the following key companies
in this industry:
- Alpharma Animal Health
- Adisseo France S.A.S.
- BASF International
- Bayer Healthcare
- Boehringer Ingelheim GmbH
- DSM Nutritional Products, Inc.
- Elanco Animal Health
- Fort Dodge Animal Health
- Heska Corporation
- Intervet Schering Plough Animal Health
- Merial Animal Health Ltd.
- Novartis Animal Health Inc.
- Virbac SA
- Pfizer Animal Health
- This report was constructed with secondary research into annual reports,
government health data, trade and medical journals, supplemented with phone
and email interviews with executives and experts in the industry. Interviews
were used to test assumptions and fix forecasts in the report.
| 
View Cart
